AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 281: L1494-L1499, 2001;
1040-0605/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kyriakides, C.
Right arrow Articles by Hechtman, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kyriakides, C.
Right arrow Articles by Hechtman, H. B.
Vol. 281, Issue 6, L1494-L1499, December 2001

Sialyl Lewisx hybridized complement receptor type 1 moderates acid aspiration injury

Constantinos Kyriakides1, Yong Wang1, William G. Austen Jr.1, Joanne Favuzza1, Lester Kobzik2, Francis D. Moore Jr.1, and Herbert B. Hechtman1

Departments of 1 Surgery and 2 Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115

The potentially enhanced anti-inflammatory effects of the sialyl Lewisx (sLex)-decorated version of soluble complement receptor type 1 (sCR1) in moderating acid aspiration injury are examined. HCl was instilled in tracheostomy tubes placed in mice, and extravasation of 125I-labeled albumin in bronchoalveolar lavage (BAL) fluid was used to calculate the vascular permeability index (PI). Neutrophil counts in BAL fluid and immunohistochemistry were performed. PI was moderated by 82% after treatment with sCR1sLex compared with 54% in sCR1-untreated mice (P < 0.05). Respective reductions in PI in mice treated 0.5 and 1 h after acid aspiration with sCR1sLex of 70 and 57% were greater than the decreases in PI of 45 and 38% observed in respective sCR1-treated groups (P < 0.05). BAL fluid neutrophil counts in sCR1sLex-treated mice were significantly less than those in sCR1-treated animals, which were similar to those in untreated mice. Immunohistochemistry stained for sCR1 only on the pulmonary vascular endothelium of sCR1sLex- but not sCR1-treated mice. In conclusion, sCR1sLex moderates permeability by antagonizing complement activation and neutrophil adhesion. Delayed complement and neutrophil antagonism significantly reduces injury.

pneumonia; murine; inflammation; complement activation; selectins


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
A. Zarbock, M. Schmolke, T. Spieker, K. Jurk, H. Van Aken, and K. Singbartl
Acute Uremia but Not Renal Inflammation Attenuates Aseptic Acute Lung Injury: A Critical Role for Uremic Neutrophils
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3124 - 3131.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. He, M. Imai, H. Song, R. J. Quigg, and S. Tomlinson
Complement Inhibitors Targeted to the Proximal Tubule Prevent Injury in Experimental Nephrotic Syndrome and Demonstrate a Key Role for C5b-9
J. Immunol., May 1, 2005; 174(9): 5750 - 5757.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
L. J. Thomas, K. Panneerselvam, D. T. Beattie, M. D. Picard, B. Xu, C. W. Rittershaus, H. C. Marsh Jr., R. A. Hammond, J. Qian, T. Stevenson, et al.
Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technology
Glycobiology, October 1, 2004; 14(10): 883 - 893.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online